Cargando…
Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
Despite extensive efforts and continual progress in research and medicine, outcomes for patients with high-grade glioma remain exceptionally poor. Over the past decade, research has revealed a great deal about the complex biology behind glioma development, and has brought to light some of the major...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427051/ https://www.ncbi.nlm.nih.gov/pubmed/28324583 http://dx.doi.org/10.1007/s40268-017-0180-1 |